Oaktree Acquisition CORP Iii Life Sciences Schedule 13G passive stakes

Decagon Asset Management LLP and Benjamin John Durham have reported beneficial ownership of 5.52% of Oaktree Acquisition Corp. III Life Sciences' Class A ordinary shares.

Barclays PLC has disclosed a beneficial ownership of 6.99% in Oaktree Acquisition Corp I-A's common stock as of June 30, 2026.

Fort Baker Capital Management LP, along with Steven Patrick Pigott and Fort Baker Capital, LLC, has disclosed a 5.1% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.2% of Oaktree Acquisition Corp III Life Sciences' Class A ordinary shares as of March 31, 2026.

Barclays PLC has reported a 4.35% beneficial ownership stake in Oaktree Acquisition Corp I-A, holding 861,625 common shares as of December 31, 2025.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have reported a 4.1% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences.

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has disclosed a 1.4% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences, holding 277,689 Class A Ordinary Shares.

The Healthcare of Ontario Pension Plan Trust Fund (HOOPP) has disclosed a 3.5% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences, holding 700,000 Class A ordinary shares.

AQR Capital Management and its affiliates have disclosed a passive 7.33% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences, holding 1,450,750 Class A ordinary shares.

Barclays PLC has reported a 7.19% beneficial ownership stake in Oaktree Acquisition Corp I-A, holding 1,299,125 common shares as of March 31, 2025.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.7% in Oaktree Acquisition Corp III Life Sciences, holding 1,337,502 Class A ordinary shares.

The Healthcare of Ontario Pension Plan Trust Fund (HOOPP) has disclosed an 8.6% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences, holding 1.7 million Class A ordinary shares.

A group of Oaktree entities has disclosed a combined beneficial ownership of 22.3% of Oaktree Acquisition Corp. III Life Sciences' Class A ordinary shares, primarily through Class B conversions and private placement securities.